Based on findings from a study published today in The Lancet Regional Health—Americas, researchers at Johns Hopkins Medicine and three collaborating medical institutions suggest that people living with the human immunodeficiency ...
Jul 24, 2023
0
34
Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the pancreatic cancer vaccine GVAX, the immune checkpoint therapy nivolumab and urelemab, an anti-CD137 agonist ...
Jul 17, 2023
0
46
For the first two weeks of life, mice with a hereditary form of deafness have nearly normal neural activity in the auditory system, according to a new study by Johns Hopkins Medicine scientists. Their previous studies indicate ...
Jun 27, 2023
0
54
Clinicians have a new standard for graft-versus-host disease (GVHD) prevention after allogeneic hematopoietic stem cell transplantation, according to results from a phase III study published June 22 in the New England Journal ...
Jun 22, 2023
0
37
Neuroscientists have long searched for ways to reopen "critical periods" in the brain, when mammals are more sensitive to signals from their surroundings that can influence periods of brain development. Now, researchers at ...
Jun 14, 2023
0
189
Johns Hopkins scientists have developed a method involving artificial intelligence to visualize and track changes in the strength of synapses—the connection points through which nerve cells in the brain communicate—in ...
Jun 5, 2023
0
96
According to the federal government's National Institute of Neurological Disorders and Stroke, nearly 3 million people worldwide—with almost a third in the United States—are living with multiple sclerosis (MS), a disabling ...
Jun 2, 2023
0
105
Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, ...
May 30, 2023
0
44
Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as ...
May 25, 2023
0
19
Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely ...
May 24, 2023
0
28
